These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 11872911

  • 1. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T, Lo EH.
    Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
    [Abstract] [Full Text] [Related]

  • 2. Extension of the thrombolytic time window with minocycline in experimental stroke.
    Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH.
    Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA, Shuaib A, Todd KG.
    Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH.
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M, Asahi K, Wang X, Lo EH.
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model.
    Tejima E, Katayama Y, Suzuki Y, Kano T, Lo EH.
    Stroke; 2001 Jun; 32(6):1336-40. PubMed ID: 11387496
    [Abstract] [Full Text] [Related]

  • 9. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.
    Aoki T, Sumii T, Mori T, Wang X, Lo EH.
    Stroke; 2002 Nov; 33(11):2711-7. PubMed ID: 12411666
    [Abstract] [Full Text] [Related]

  • 10. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 11. Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
    Copin JC, Merlani P, Sugawara T, Chan PH, Gasche Y.
    Exp Neurol; 2008 Sep; 213(1):196-201. PubMed ID: 18590727
    [Abstract] [Full Text] [Related]

  • 12. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M, Rammohan R, Sumii T, Wang X, Pauw RJ, Weissig V, Torchilin VP, Lo EH.
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [Abstract] [Full Text] [Related]

  • 13. PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.
    Jin R, Xiao AY, Li J, Wang M, Li G.
    Hypertension; 2019 Jan; 73(1):206-216. PubMed ID: 30571560
    [Abstract] [Full Text] [Related]

  • 14. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S, Planz O, Schwaninger M.
    Cerebrovasc Dis Extra; 2016 Jan; 6(2):50-9. PubMed ID: 27560521
    [Abstract] [Full Text] [Related]

  • 15. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia.
    Hamann GF, Burggraf D, Martens HK, Liebetrau M, Jäger G, Wunderlich N, DeGeorgia M, Krieger DW.
    Stroke; 2004 Mar; 35(3):764-9. PubMed ID: 14976330
    [Abstract] [Full Text] [Related]

  • 16. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M, Allahtavakoli F, Hassanipour M, Khaksari M, Rezazadeh H, Allahtavakoli M, Taghavi MM.
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [Abstract] [Full Text] [Related]

  • 17. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M, Kawasaki K, Suzuki Y, Ishizuka F, Mishiro K, Egashira Y, Ikegaki I, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H.
    Neuroscience; 2012 Sep 18; 220():302-12. PubMed ID: 22710066
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC.
    Stroke; 1998 May 18; 29(5):1020-30. PubMed ID: 9596253
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
    Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH.
    Stroke; 2004 Nov 18; 35(11 Suppl 1):2726-30. PubMed ID: 15459442
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH.
    Nat Med; 2003 Oct 18; 9(10):1313-7. PubMed ID: 12960961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.